CUSIP 05338F306COM NEWAVTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
84 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bvf Inc/Il | 1.36M | $24.61M | +1 | Added |
| 2 | Nantahala Capital Management, LLC | 1.24M | $22.43M | 0 | Held |
| 3 | Orbimed Advisors LLC | 1.19M | $21.56M | −162.0K | Reduced |
| 4 | Affinity Asset Advisors, LLC | 1.05M | $19.09M |
| +44.8K |
| Added |
| 5 | Caligan Partners LP | 881.5K | $16.01M | +48.2K | Added |
| 6 | Vanguard Group Inc | 804.1K | $14.60M | +111.4K | Added |
| 7 | Ra Capital Management, L.P. | 663.0K | $12.04M | 0 | Held |
| 8 | Millennium Management LLC | 660.0K | $11.99M | +522.5K | Added |
| 9 | Point72 Asset Management, L.P. | 627.5K | $11.40M | −426.5K | Reduced |
| 10 | Bank Of America Corp /De/ | 621.4K | $11.28M | +15.5K | Added |
See every fund holding Avalo Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders